AMENDMENT N0. 1 --------------- TO -- KIRIN-AMGEN, INC./AMGEN ----------------------- G-CSF EUROPEAN LICENSE AGREEMENT --------------------------------G-CSF European License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2001 Company Industry
AMENDMENT NO. 2 --------------- TO -- KIRIN-AMGEN, INC./AMGEN ----------------------- G-CSF EUROPEAN LICENSE AGREEMENT -------------------------------- THIS AMENDMENT NO. 2 ("Amendment No. 2") TO THAT CERTAIN KIRIN-AMGEN, INC./AMGEN G-CSF EUROPEAN...G-CSF European License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2001 Company Industry
Exhibit 10.34 ------------- AMENDMENT NO. 4 --------------- TO -- KIRIN-AMGEN, INC./AMGEN ----------------------- G-CSF EUROPEAN LICENSE AGREEMENT --------------------------------G-CSF European License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2001 Company Industry
AMENDMENT NO. 3 --------------- TO -- KIRIN-AMGEN, INC./AMGEN ----------------------- G-CSF EUROPEAN LICENSE AGREEMENT --------------------------------G-CSF European License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2001 Company Industry
by and betweenG-CSF European License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 7th, 2001 Company Industry Jurisdiction